Skip to main content
Jane Titterington, MD, Cardiology, Kansas City, KS

Jane Sibley Titterington MD PhD

Heart Failure & Transplantation


Cardiology Fellow

Join to View Full Profile
  • 4000 Cambridge StSte G600Kansas City, KS 66160

  • Phone+1 913-588-9700

  • Fax+1 913-588-9770

Dr. Titterington is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 2017 - 2018
  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Cardiovascular Disease, 2012 - 2017
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 2010
  • Kansas State University
    Kansas State UniversityB.A., Microbiology major, Spanish minor, 1998 - 2002

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2018 - 2023
  • MO State Medical License
    MO State Medical License 2018 - 2023
  • GA State Medical License
    GA State Medical License Active through 2018

Awards, Honors, & Recognition

  • Haymaker Award Kansas State University Division of Biology, 2002
  • Phi Beta Kappa 2002
  • Research Award Kansas State University Center for Basic Cancer, 2001
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Growth hormone-releasing peptide-2 reduces oxidative stress in ApoE -/- mice but does not reduce atherosclerosis.
    Titterington JS, Sukhanov S, Vaughn CE, Delafontaine P, FASEB J, 1/1/2009
  • Insulin-like growth factor I downregulates lipoprotein lipase and suppresses atherosclerotic foam cell formation in vivo and in vitro.
    Sukhanov S. Vaughn CE, Higashi Y, Titterington JS, Delafontaine P, FASEB J, 1/1/2009
  • Chronic Left-Ventricular Dysfunction Increases Oxidative Stress in Skeletal Muscle: Potential Mechanism of Cardiac Cachexia.
    Semprun-Prieto L, Sukhanov S, Bhutto J, Titterington JS, Delafontaine P, FASEB J, 1/1/2009
  • Join now to see all

Lectures

  • Growth hormone-releasing peptide-2 reduces oxidative stress in ApoE -/- mice but does not reduce atherosclerosis. 
    Experimental Biology - 4/1/2009
  • Insulin-like growth factor I downregulates lipoprotein lipase and suppresses atherosclerotic foam cell formation in vivo and in vitro. 
    Experimental Biology - 4/1/2009
  • Chronic Left-Ventricular Dysfunction Increases Oxidative Stress in Skeletal Muscle: Potential Mechanism of Cardiac Cachexia. 
    Experimental Biology - 4/1/2009
  • Join now to see all

Press Mentions

  • Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium Is Associated with an Improved Cardiac Phenotype
    Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium Is Associated with an Improved Cardiac PhenotypeJanuary 7th, 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: